Reuters logo
BRIEF-Cure Pharma says Oak Therapeutics completes milestone in phase 1 of NIH grant
August 22, 2017 / 2:21 PM / a month ago

BRIEF-Cure Pharma says Oak Therapeutics completes milestone in phase 1 of NIH grant

Aug 22 (Reuters) - Cure Pharmaceutical Holding Corp :

* Oak Therapeutics completed critical milestone in phase 1 of NIH grant to develop oral dissolvable strip for tuberculosis

* Unit Oak Therapeutics is currently in the application process for phase II of the SBIR program Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below